Back to Search Start Over

No Evidence for Histamine H4Receptor in Human Monocytes

Authors :
Detlef Neumann
Kristin Werner
Roland Seifert
Armin Buschauer
Source :
Journal of Pharmacology and Experimental Therapeutics. 351:519-526
Publication Year :
2014
Publisher :
American Society for Pharmacology & Experimental Therapeutics (ASPET), 2014.

Abstract

The histamine H4 receptor (H4R) is a classic pertussis toxin-sensitive Gi protein-coupled receptor that mediates increases in intracellular calcium concentration ([Ca(2+)]i). The presence of H4R in human eosinophils has been rigorously documented by several independent groups. It has also been suggested that H4R is expressed in human monocytes, but this suggestion hinges in part on H4R antibodies with questionable specificity. This situation prompted us to reinvestigate H4R expression in human monocytes. As positive control, we studied human embryonic kidney 293T cells stably expressing the human H4R (hH4R). In these cells, histamine (HA) and the H4R agonist UR-PI376 (2-cyano-1-[4-(1H-imidazol-4-yl)butyl]-3-[(2-phenylthio)ethyl]guanidine) induced pertussis toxin-sensitive [Ca(2+)]i increases. However, in quantitative real-time polymerase chain reaction studies we failed to detect hH4R mRNA in human monocytes and U937 promonocytes. In human monocytes, ATP and N-formyl-l-methionyl-l-leucyl-l-phenylalanine increased [Ca(2+)]i, but HA, UR-PI376, and 5-methylhistamine (a dual H4R/H2 receptor agonist) did not. In U937 promonocytes and differentiated U937 cells, HA increased [Ca(2+)]i, but this increase was mediated via HA H1 receptor. In conclusion, there is no evidence for the presence of H4R in human monocytes.

Details

ISSN :
15210103 and 00223565
Volume :
351
Database :
OpenAIRE
Journal :
Journal of Pharmacology and Experimental Therapeutics
Accession number :
edsair.doi.dedup.....d75b79e26d4afce6fd05a878af44ee91
Full Text :
https://doi.org/10.1124/jpet.114.218107